Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
18 hedge funds and large institutions have $42.5M invested in Entasis Therapeutics Holdings Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
11% less capital invested
Capital invested by funds: $48M → $42.5M (-$5.49M)
14% less funds holding
Funds holding: 21 → 18 (-3)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.64M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$86.2K |
| 3 |
Renaissance Technologies
New York
|
+$41.1K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$35K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$11K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 4 |
BlackRock
New York
|
-$888 |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$298 |
ETTX Hedge Fund Activity: Q4 2019 in Review
18 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q4 2019, worth a combined $42.5M — down 11% from $48M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ETTX and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Eventide Asset Management, adding an estimated $2.64M. The largest seller was Bank of Montreal, exiting entirely with an estimated $35K sold.
- 18 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q4 2019, down from 21 in Q3 2019.
- Funds reported $42.5M of Entasis Therapeutics Holdings Inc. stock for Q4 2019, down 11% quarter-over-quarter.
- 0 funds opened new Entasis Therapeutics Holdings Inc. positions in Q4 2019 and 3 closed out, a net change of -3 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q4 2019 was Eventide Asset Management, an estimated $2.64M added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q4 2019 was Bank of Montreal, an estimated $35K sold.
Based on aggregated 13F filings for Q4 2019.